Use of Nanoscaffold Augmentation in Rotator Cuff Repair: Clinical Outcome and Ultrasound Assessment of Healing Rates and Vascularity
Primary Purpose
Rotator Cuff Tears, Rotator Cuff Injuries, Rotator Cuff Syndrome of Shoulder and Allied Disorders
Status
Withdrawn
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Rotium nanoscaffold
Control arm rotator cuff repair
Sponsored by
About this trial
This is an interventional treatment trial for Rotator Cuff Tears
Eligibility Criteria
Inclusion Criteria:
- -symptomatic supraspinatus or supraspinatus and infraspinatus tear that can be repaired to the greater tuberosity in an anatomical manner using a dual layer repair technique.
- also included will be patients that have concomitant pathology addressed at time of surgery, specifically pathologies of the biceps tendon (tenodesis or tenotomy), arthrosis of the acromioclavicular joint (distal clavicle resection), or labral tearing (debridement or repair)
- included age range of subjects will be from 18-80 years old
Exclusion Criteria:
- diabetes, cancer or medical states that may impair healing, such as organ transplantation or systemic inflammatory process treated with immune modulating drugs (chemotherapy, immunosuppression drugs)
- prior surgery to the ipsilateral rotator cuff tendon
- need of soft tissue releases to accomplish an anatomic repair, partial repairs and/or concomitant subscapularis repair
- significant glenohumeral arthritis
- active or ongoing infection
- pregnancy
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Rotium patch recipient
Control
Arm Description
Subjects with Rotium nano scaffold patch included in rotator cuff repair construct
Subjects undergoing non-patch augmented rotator cuff repair
Outcomes
Primary Outcome Measures
Rotator cuff integrity baseline/preoperative
ultrasound assessment of rotator cuff
Rotator cuff repair integrity @ 2 weeks
ultrasound assessment of rotator cuff
Rotator cuff repair integrity @ 4 weeks
ultrasound assessment of rotator cuff
Rotator cuff repair integrity @ 6 weeks
ultrasound assessment of rotator cuff
Rotator cuff repair integrity @ 3 months
ultrasound assessment of rotator cuff
Rotator cuff repair integrity @ 6 months
ultrasound assessment of rotator cuff
Rotator cuff repair integrity @ 12 months
ultrasound assessment of rotator cuff
Postoperative rotator cuff vascularity during healing
ultrasound assessment of rotator cuff at repair site using superb microvascular imaging (SMI)
Postoperative rotator cuff vascularity during healing
ultrasound assessment of rotator cuff at repair site using superb microvascular imaging (SMI)
Postoperative rotator cuff vascularity during healing
ultrasound assessment of rotator cuff at repair site using superb microvascular imaging (SMI)
Postoperative rotator cuff vascularity during healing
ultrasound assessment of rotator cuff at repair site using superb microvascular imaging (SMI)
Postoperative rotator cuff vascularity during healing
ultrasound assessment of rotator cuff at repair site using superb microvascular imaging (SMI)
Postoperative rotator cuff vascularity during healing
ultrasound assessment of rotator cuff at repair site using superb microvascular imaging (SMI)
Secondary Outcome Measures
University California Los Angeles Shoulder score
Outcome score
Rowe score
Outcome score
Constant score
Outcome score
American shoulder and elbow surgeons score
Outcome score
SANE score
Outcome score
Full Information
NCT ID
NCT04361266
First Posted
April 17, 2020
Last Updated
October 16, 2022
Sponsor
Joshua Szabo, MD
Collaborators
Atreon Orthopedics
1. Study Identification
Unique Protocol Identification Number
NCT04361266
Brief Title
Use of Nanoscaffold Augmentation in Rotator Cuff Repair: Clinical Outcome and Ultrasound Assessment of Healing Rates and Vascularity
Official Title
Use of Nanoscaffold Augmentation in Rotator Cuff Repair: Clinical Outcome and Ultrasound Assessment of Healing Rates and Vascularity
Study Type
Interventional
2. Study Status
Record Verification Date
October 2022
Overall Recruitment Status
Withdrawn
Why Stopped
withdrawn
Study Start Date
August 1, 2022 (Anticipated)
Primary Completion Date
August 1, 2023 (Anticipated)
Study Completion Date
November 1, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Joshua Szabo, MD
Collaborators
Atreon Orthopedics
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose is to assess Rotium, a novel nanoscaffold, impact on healing of a repaired rotator cuff and compare to a repair without Rotium. Animal (sheep) models have shown both quicker and more organized healing when Rotium is used, but there are no studies to confirm these outcomes translate to human population.
Hypothesis: Rotium rotator cuff repairs will heal both quicker and better than traditional rotator cuff repair techniques.
Detailed Description
Patients indicated for rotator cuff repair surgery will be offered participation within the study and consented accordingly. A copy of the consent will be provided to the participant. A preoperative ultrasonographic assessment will occur by Dr. Onishi. A randomization process by computer program will determine patients who have Rotium augmented repairs, or not. The patients will not be blinded.
The surgery will be carried out by a single surgeon making all aspects uniform, except if there is or is not a Rotium patch. The Rotium patch will be implanted in accordance to standards of handling sterile implants and placed in a manner that is consistent to its FDA approval. The patch will be furnished by the institution where the surgery is being performed. Digital photography will document pertinent arthroscopic operative findings per standard of care.
Participant assessment will commence preoperatively in an outpatient clinic then continue in postoperative period, occurring at 2, 4, 6 weeks and 3, 6 and 12 month intervals. During each visit, the participants will be assessed by two clinicians: the principal investigator and a blinded ultrasonographer.
Preoperative assessment will include obtaining baseline patient reported outcomes (UCLA, Rowe, Constant, American Shoulder and Elbow Surgeons (ASES) score and SANE (Single Alpha Numeric Evaluation)scores) by paper questionnaire. A medical history will document NSAID use, cortisone injections about the shoulder, tobacco usage, narcotic medicine consumption, and pregnancy status. Due to their deleterious effects on healing, all patients will be instructed to not take NSAIDs in the first 6 weeks postoperative. Noncompliance will be noted, but not disqualify the participant from study. Smoking cessation will be strongly encouraged. A shoulder physical examination will be performed; specifically range of motion assessment in multiple planes (frontal flexion, internal and external rotation at 90 degrees of abduction and at side), rotator cuff muscle strength testing with the scapula stabilized, scapula posture observed, and provocative tests for impingement syndrome. Medical records will be reviewed. This evaluation will be performed by the principal investigator and will take 45-60 minutes. The participant will undergo a separate diagnostic ultrasonographic assessment of the rotator cuff tendons by blinded ultrasonographer. This will take 15-30 minutes.
Aftercare of each population will be identical and will include a 6-week period of sling immobilization, brief perioperative narcotic medicine, and physical therapy. Physical therapy protocols will be identical. The participants will be treated by a variety of physical therapists. All physical therapy will occur out of the home at a PT clinic. Additional home exercises will be furnished and will be independently performed by the participants.
Specifically, at the 2-week postoperative visit a history will be obtained to quantify narcotic usage, NSAID usage, VAS pain score, and assess for any complications. The surgical site and sling will be inspected, passive range of motion of the shoulder assessed (frontal flexion and external rotation at the side), and the examine will exclude any complications. Physical therapy for shoulder passive range of motion and periscapular strengthening will be prescribed, home exercise sheet provided, and the abduction portion of the sling will be discontinued. Shoulder radiographs will be performed. This visit will take 15-30 minutes. In addition and separate to this,blinded ultrasonographer will perform ultrasound assessment of the repaired rotator cuff. Vascularity using superb microvascular imaging and standard ultrasound techniques will assess vascularity and rotator cuff repair integrity. If possible, elastography will be performed. These images will be stored in de-identified manner within University of Pittsburgh HIPPA-compliant cloud. This will take 15-30 minutes and may be done at a separate time.
At the 4-week postoperative visit a history will be obtained to quantify narcotic usage, NSAID usage, pain score, and assess for any complications. The surgical site and sling will be inspected, passive range of motion of the shoulder (frontal flexion and external rotation at the side) assessed, and the examine will exclude any complications. The prior physical therapy and home exercises will be continued. This visit will take 15-30 minutes. In addition and separate to this, blinded ultrasonographer will perform ultrasound assessment of the repaired rotator cuff. This will take 15-30 minutes and may be done at a separate time.
At the 6-week postoperative visit a history will be obtained to quantify narcotic usage, NSAID usage, pain score, and assess for any complications. The surgical site and sling will be inspected, passive range of motion of the shoulder (frontal flexion, internal and external rotation at 90 degrees of abduction and at side) assessed, and the examine will exclude any complications. The sling will be discontinued and new physical therapy and home exercises will be provided; therapy will include shoulder passive range of motion and periscapular strengthening and include rotator cuff strengthening progressing from isometric to concentric then to eccentric with the pace being determined by a physical therapist, but done in a pain free manner. Additionally, patient reported outcomes (UCLA, Rowe, Constant, ASES and SANE scores) will be collected. This visit will take 30-45 minutes. In addition and separate to this, blinded ultrasonographer will perform ultrasound assessment of the repaired rotator cuff. This will take 15-30 minutes and may be done at a separate time.
At the 3-, 6- and 12-month postoperative visits a history will be obtained to assess shoulder functionality/limitations, quantify NSAID usage, pain score, and assess for any complications. The examination will be similar to the 6-week evaluation, except rotator cuff specific strength will be assessed similar to the preoperative testing. Necessity of ongoing physical therapy will be considered and ordered appropriately. Home exercises will be continued. These visits will take 30-45 minutes. In addition and separate to this, blinded ultrasonographer will perform ultrasound assessment of the repaired rotator cuff. This will take 15-30 minutes and may be done at a separate time.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Rotator Cuff Tears, Rotator Cuff Injuries, Rotator Cuff Syndrome of Shoulder and Allied Disorders
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
prospective randomized control trial
Masking
Investigator
Masking Description
Blinded ultrasound assessment
Allocation
Randomized
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Rotium patch recipient
Arm Type
Experimental
Arm Description
Subjects with Rotium nano scaffold patch included in rotator cuff repair construct
Arm Title
Control
Arm Type
Active Comparator
Arm Description
Subjects undergoing non-patch augmented rotator cuff repair
Intervention Type
Device
Intervention Name(s)
Rotium nanoscaffold
Intervention Description
Rotium bioabsorbable nanoscaffold placed between bone-tendon interface of rotator cuff repair construct
Intervention Type
Procedure
Intervention Name(s)
Control arm rotator cuff repair
Intervention Description
Standard rotator cuff repair without Rotium
Primary Outcome Measure Information:
Title
Rotator cuff integrity baseline/preoperative
Description
ultrasound assessment of rotator cuff
Time Frame
preoperative
Title
Rotator cuff repair integrity @ 2 weeks
Description
ultrasound assessment of rotator cuff
Time Frame
postoperative at 2 weeks
Title
Rotator cuff repair integrity @ 4 weeks
Description
ultrasound assessment of rotator cuff
Time Frame
postoperative at 4 weeks
Title
Rotator cuff repair integrity @ 6 weeks
Description
ultrasound assessment of rotator cuff
Time Frame
postoperative at 6 weeks
Title
Rotator cuff repair integrity @ 3 months
Description
ultrasound assessment of rotator cuff
Time Frame
postoperative 3 months
Title
Rotator cuff repair integrity @ 6 months
Description
ultrasound assessment of rotator cuff
Time Frame
postoperative at 6 months
Title
Rotator cuff repair integrity @ 12 months
Description
ultrasound assessment of rotator cuff
Time Frame
postoperative at 12 months
Title
Postoperative rotator cuff vascularity during healing
Description
ultrasound assessment of rotator cuff at repair site using superb microvascular imaging (SMI)
Time Frame
postoperative at 2 weeks
Title
Postoperative rotator cuff vascularity during healing
Description
ultrasound assessment of rotator cuff at repair site using superb microvascular imaging (SMI)
Time Frame
postoperative at 4 weeks
Title
Postoperative rotator cuff vascularity during healing
Description
ultrasound assessment of rotator cuff at repair site using superb microvascular imaging (SMI)
Time Frame
postoperative at 6 weeks
Title
Postoperative rotator cuff vascularity during healing
Description
ultrasound assessment of rotator cuff at repair site using superb microvascular imaging (SMI)
Time Frame
postoperative at 3 months
Title
Postoperative rotator cuff vascularity during healing
Description
ultrasound assessment of rotator cuff at repair site using superb microvascular imaging (SMI)
Time Frame
postoperative at 6 months
Title
Postoperative rotator cuff vascularity during healing
Description
ultrasound assessment of rotator cuff at repair site using superb microvascular imaging (SMI)
Time Frame
postoperative at 12 months
Secondary Outcome Measure Information:
Title
University California Los Angeles Shoulder score
Description
Outcome score
Time Frame
preoperative and postoperative at 6 weeks and 3,6,12 months postoperative
Title
Rowe score
Description
Outcome score
Time Frame
preoperative and postoperative at 6 weeks and 3,6,12 months postoperative
Title
Constant score
Description
Outcome score
Time Frame
preoperative and postoperative at 6 weeks and 3,6,12 months postoperative
Title
American shoulder and elbow surgeons score
Description
Outcome score
Time Frame
preoperative and postoperative at 6 weeks and 3,6,12 months postoperative
Title
SANE score
Description
Outcome score
Time Frame
preoperative and postoperative at 2,4, 6 weeks and 3,6,12 months postoperative
Other Pre-specified Outcome Measures:
Title
NSAID usage
Description
total dosage of NSAIDs
Time Frame
postoperative period @ 2,4, 6 weeks and 3, 6, 12 months
Title
Cortisone injections about the shoulder
Description
Include total number and timeframe relative to surgical date
Time Frame
preoperative period
Title
Tobacco usage
Description
Daily consumption
Time Frame
preoperative and postoperative periods @ 2,4, 6 weeks and 3, 6, 12 months
Title
Narcotic consumption
Description
total dosage of narcotic medicine
Time Frame
postoperative period @ 2,4, 6 weeks and 3, 6, 12 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
-symptomatic supraspinatus or supraspinatus and infraspinatus tear that can be repaired to the greater tuberosity in an anatomical manner using a dual layer repair technique.
also included will be patients that have concomitant pathology addressed at time of surgery, specifically pathologies of the biceps tendon (tenodesis or tenotomy), arthrosis of the acromioclavicular joint (distal clavicle resection), or labral tearing (debridement or repair)
included age range of subjects will be from 18-80 years old
Exclusion Criteria:
diabetes, cancer or medical states that may impair healing, such as organ transplantation or systemic inflammatory process treated with immune modulating drugs (chemotherapy, immunosuppression drugs)
prior surgery to the ipsilateral rotator cuff tendon
need of soft tissue releases to accomplish an anatomic repair, partial repairs and/or concomitant subscapularis repair
significant glenohumeral arthritis
active or ongoing infection
pregnancy
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
There is no plan to share data at this time.
Learn more about this trial
Use of Nanoscaffold Augmentation in Rotator Cuff Repair: Clinical Outcome and Ultrasound Assessment of Healing Rates and Vascularity
We'll reach out to this number within 24 hrs